Evidence map›Paper›PMID 27044402›Full record

ArticleBMC gastroenterology2016

Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot study.

Zobair M Younossi, Louis L LaLuna, John J Santoro, Flavia Mendes, Victor Araya, Natarajan Ravendhran, Lisa Pedicone, Idania Lio, Fatema Nader, Sharon Hunt and 2 more

Abstract readMulticenter Study
In one paragraph

Article in BMC gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Hepatitis C Screening: Barriers to Linkage to Care.Journal of clinical and translational hepatology · 2019
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zobair M YounossiCenter for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA. zobair.younossi@inova.org.
Louis L LaLunaDigestive Disease Associates, Wyomissing, PA, USA.
John J SantoroAGA Clinical Research Associates, LLC, Egg Harbor Township, NJ, USA.
Flavia MendesGastroHealth, Miami, FL, USA.
Victor ArayaCentral Bucks Specialists, Gastroenterology, Doylestown, PA, USA.
Natarajan RavendhranDigestive Diseases Associates, Catonsville, MD, USA.
Lisa PediconeCantara Clinical Solutions, LLC, Morristown, NJ, USA.
Idania LioCantara Clinical Solutions, LLC, Morristown, NJ, USA.
Fatema NaderCenter for Outcomes Research in Liver Diseases, Washington, DC, USA.
Sharon HuntCenter for Outcomes Research in Liver Diseases, Washington, DC, USA.
Andrei RacilaCenter for Outcomes Research in Liver Diseases, Washington, DC, USA.
Maria StepanovaCenter for Outcomes Research in Liver Diseases, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEstimates suggest that only 20 % of HCV-infected patients have been identified and <10 % treated. However, baby boomers (1945-1965) are identified as having a higher prevalence of HCV which has led the Centers for Disease Control and Prevention to make screening recommendations. The aim of this study was to implement the CDC's screening recommendations in the unique setting of gastroenterology practices in patients previously unscreened for HCV.

methodsAfter obtaining patient informed consent, demographics, clinical and health-related quality of life (HRQOL) data were collected. A blood sample was screened for HCV antibody (HCV AB) using the OraQuick HCV Rapid Antibody Test. HCV AB-positive patients were tested for presence of HCV RNA and, if HCV RNA positive, patients underwent treatment discussions.

resultsWe screened 2,000 individuals in 5 gastroenterology centers located close to large metropolitan areas on the East Coast (3 Northeast, 1 Mid-Atlantic and 1 Southeast). Of the screened population, 10 individuals (0.5 %) were HCV AB-positive. HCV RNA testing was performed in 90 % (9/10) of HCV AB-positive individuals. Of those, 44.4 % (4/9) were HCV RNA-positive, and all 4 (100 %) were linked to caregiver. Compared to HCV AB negative subjects, HCV AB-positive individuals tended to be black (20.0 vs. 5.2 %, p = 0.09) and reported significantly higher rates of depression: 60.0 vs. 21.5 %, p = 0.009. These individuals also reported a significantly lower HRQOL citing having more fatigue, poorer concentration, and a decreased level of energy (p < 0.05). DISCUSSION: Although the prevalence of HCV AB-positive was low in previously unscreened subjects screened in the gastroenterology centers, the linkage to care was very high. The sample of patients used in this study may be biased, so further studies are needed to assess the effectiveness of the CDC screening recommendations.

conclusionImplementation of the Baby Boomer Screening for HCV requires identifying screening environement with high prevalence of HCV+ individuals as well as an efficient process of linking them to care.

Indexed as

AgedBlack or African AmericanCenters for Disease Control and Prevention, U.S.DepressionFemaleGastroenterologyHepatitis CHepatitis C AntibodiesHumansMaleMass ScreeningMiddle AgedPilot ProjectsPractice Guidelines as TopicPrevalenceRNA, ViralHepatitis C AntibodiesRNA, Viral

Identifiers

PMID27044402
PMCPMC4820944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.